The NOACs (Novel Oral Anticoagulants) have landed!

American Journal of Medicine

Volumn 127, Issue 11, 2014, Pages 1027-1028

  Joseph S, Alpert ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; APIXABAN; DABIGATRAN; EDOXABAN; RIVAROXABAN; WARFARIN; ACETYLSALICYLIC ACID; ANTIVITAMIN K; CLOPIDOGREL; DABIGATRAN ETEXILATE;

ANTICOAGULANT THERAPY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; INTERNATIONAL NORMALIZED RATIO; PRESCRIPTION; ATRIAL FIBRILLATION; ECONOMICS; FEMALE; HUMAN; MALE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL MEDICINE; CLINICAL PROTOCOL; DEEP VEIN THROMBOSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; LUNG EMBOLISM; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE;

EID: 84912085407     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2014.07.028     Document Type: Editorial

References (10)

1. Connolly SJ, Ezekowitz MD, Yusuf S, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151, Erratum in: N Engl J Med. 2010;363:1877.
2. Manesh RP, Mahaffey KW, Garg J, et al; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-891.
3. Granger CB, Alexander JH, McMurray JJV, et al; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fi brillation. N Engl J Med. 2011;365:981-992.
4. Giugliano RP, Ruff CT, Braunwald E, et al; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093-2104.
5. Desai NR, Krumme AA, Schneeweiss S, et al. Patterns of initiation of oral anticoagulants in patients with atrial fibrillation-quality and cost implications. Am J Med. 2014 May 20:[Epub ahead of print].
6. Eikelboom JW, Connolly SJ, Brueckmann M, et al; RE-ALIGN Investigators. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369:1206-1214.
7. PIONEER AF-PCI trial. Available at: http://clinicaltrials.gov/show/NCT01830543. Accessed July 17, 2014.
8. Ascencio LA, Huang JJ, Alpert JS. Combining antiplatelet and antithrombotic therapy (triple therapy): what are the risks and benefits. Am J Med. 2014;127:579-585.
9. Wahl MJ. Dental surgery and antiplatelet agents: bleed or die. Am J Med. 2014;127:260-267.
10. Di Biase L, Burkhardt JD, Santangeli P, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management. Results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Circulation. 2014;129:2638-2644.